These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Preliminary studies on the differential expression of adrenocorticotropic hormone receptor in adrenal adenomas. Hu D; Liu T; Wang X Endokrynol Pol; 2017; 68(5):512-518. PubMed ID: 28879651 [TBL] [Abstract][Full Text] [Related]
63. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. Heikinheimo K; Jee KJ; Niini T; Aalto Y; Happonen RP; Leivo I; Knuutila S J Dent Res; 2002 Aug; 81(8):525-30. PubMed ID: 12147741 [TBL] [Abstract][Full Text] [Related]
64. [Diagnosis of aldosterone-secreting adenoma of the adrenal cortex]. Bar-Andziak E; Chodakowska J; Feltynowski T; Ignatowska-Switalska H; Wocial B Pol Tyg Lek; 1982 Nov; 37(44):1309-14. PubMed ID: 7163084 [No Abstract] [Full Text] [Related]
65. Role of Nox2 and p22phox in Persistent Postoperative Hypertension in Aldosterone-Producing Adenoma Patients after Adrenalectomy. Geng X; Yan L; Dong J; Liang Y; Deng Y; Li T; Luo T; Lin H; Zhang S Int J Endocrinol; 2016; 2016():2395634. PubMed ID: 27057164 [TBL] [Abstract][Full Text] [Related]
66. Apoptosis as a Prognostic Factor in Colorectal Carcinoma: Comparison of TUNEL Method and Immunohistochemical Expression of Caspase-3. Kunac N; Šundov Ž; Vilović K Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):e22-e27. PubMed ID: 29489504 [TBL] [Abstract][Full Text] [Related]
67. Primary aldosteronism: molecular medicine meets public health. Azizan EAB; Drake WM; Brown MJ Nat Rev Nephrol; 2023 Dec; 19(12):788-806. PubMed ID: 37612380 [TBL] [Abstract][Full Text] [Related]
68. Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production. Wu X; Azizan EAB; Goodchild E; Garg S; Hagiyama M; Cabrera CP; Fernandes-Rosa FL; Boulkroun S; Kuan JL; Tiang Z; David A; Murakami M; Mein CA; Wozniak E; Zhao W; Marker A; Buss F; Saleeb RS; Salsbury J; Tezuka Y; Satoh F; Oki K; Udager AM; Cohen DL; Wachtel H; King PJ; Drake WM; Gurnell M; Ceral J; Ryska A; Mustangin M; Wong YP; Tan GC; Solar M; Reincke M; Rainey WE; Foo RS; Takaoka Y; Murray SA; Zennaro MC; Beuschlein F; Ito A; Brown MJ Nat Genet; 2023 Jun; 55(6):1009-1021. PubMed ID: 37291193 [TBL] [Abstract][Full Text] [Related]
70. Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation. Tetti M; Gong S; Veglio F; Reincke M; Williams TA Front Endocrinol (Lausanne); 2022; 13():934326. PubMed ID: 36004349 [TBL] [Abstract][Full Text] [Related]
71. Transcriptomics, Epigenetics, and Metabolomics of Primary Aldosteronism. Spyroglou A; Piaditis GP; Kaltsas G; Alexandraki KI Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771744 [TBL] [Abstract][Full Text] [Related]
72. Primary Aldosteronism: Metabolic Reprogramming and the Pathogenesis of Aldosterone-Producing Adenomas. Gong S; Tetti M; Reincke M; Williams TA Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359615 [TBL] [Abstract][Full Text] [Related]
73. The Age-Dependent Changes of the Human Adrenal Cortical Zones Are Not Congruent. Tezuka Y; Atsumi N; Blinder AR; Rege J; Giordano TJ; Rainey WE; Turcu AF J Clin Endocrinol Metab; 2021 Apr; 106(5):1389-1397. PubMed ID: 33524149 [TBL] [Abstract][Full Text] [Related]
74. The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma. Oki K; Gomez-Sanchez CE Endocr J; 2020 Oct; 67(10):989-995. PubMed ID: 32968034 [TBL] [Abstract][Full Text] [Related]
75. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth. Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799 [TBL] [Abstract][Full Text] [Related]
76. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism. Aristizabal Prada ET; Castellano I; Sušnik E; Yang Y; Meyer LS; Tetti M; Beuschlein F; Reincke M; Williams TA Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642543 [TBL] [Abstract][Full Text] [Related]
77. Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues. Zhou J; Lam B; Neogi SG; Yeo GS; Azizan EA; Brown MJ Hypertension; 2016 Dec; 68(6):1424-1431. PubMed ID: 27777363 [TBL] [Abstract][Full Text] [Related]
78. ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions. Mulatero P; Schiavi F; Williams TA; Monticone S; Barbon G; Opocher G; Fallo F J Hum Hypertens; 2016 Jun; 30(6):374-8. PubMed ID: 26446392 [TBL] [Abstract][Full Text] [Related]
79. Issues in the Diagnosis and Treatment of Primary Aldosteronism. Burrello J; Monticone S; Buffolo F; Tetti M; Giraudo G; Schiavone D; Veglio F; Mulatero P High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):73-82. PubMed ID: 25854140 [TBL] [Abstract][Full Text] [Related]
80. Granulocyte-colony stimulating factor activates JAK2/PI3K/PDE3B pathway to inhibit corticosterone synthesis in a neonatal hypoxic-ischemic brain injury rat model. Charles MS; Drunalini Perera PN; Doycheva DM; Tang J Exp Neurol; 2015 Oct; 272():152-9. PubMed ID: 25816736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]